GRTX
Galera Therapeutics, Inc.Company with tickers: GRTX
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-15 | Emerald Bioventures, LLC |
10% Owner | Other | 20,813 |
| 2026-05-15 | Emerald Bioventures, LLC |
10% Owner | Other | 20,813,818 |
| 2026-04-07 | FRIEDMAN MICHAEL R. |
Director | Other | 5,336,870 |
| 2026-04-07 | FRIEDMAN MICHAEL R. |
Director | Other | 5,336 |
| 2026-04-07 | CHANG NANCY T |
Director, 10% Owner | Other | 1,180,611 |
| 2026-04-07 | CHANG NANCY T |
Director, 10% Owner | Other | 1,180 |
| 2025-11-20 | Sorensen Mel |
Director, President and CEO | Sell | 70,000 |
| 2025-05-01 | Sussman Joel F. |
Chief Accounting Officer | Award | 2,000,000 |
| 2025-05-01 | Sorensen Mel |
Director, President and CEO | Award | 6,000,000 |
| 2025-02-24 | FRIEDMAN MICHAEL R. |
Director | Award | 96,000 |
| 2025-02-24 | Alleva Lawrence M |
Director | Award | 48,000 |
| 2025-02-24 | LOKAY KEVIN G |
Director | Award | 48,000 |
| 2025-02-24 | CHANG NANCY T |
Director, 10% Owner | Award | 96,000 |
| 2024-12-30 | FRIEDMAN MICHAEL R. |
Director | Award | 8,326 |
| 2024-12-30 | CHANG NANCY T |
Director, 10% Owner | Buy | 7,644,932 |
| 2024-12-30 | CHANG NANCY T |
Director, 10% Owner | Other | 0 |
| 2024-12-30 | FRIEDMAN MICHAEL R. |
Director | Other | 0 |
| 2024-12-30 | CHANG NANCY T |
Director, 10% Owner | Award | 1,841 |
| 2024-08-16 | Sorensen Mel |
Director, President and CEO | Sell | 67,015 |
| 2024-02-08 | Schneid Yair |
10% Owner | Buy | 150,000 |
| 2024-02-07 | Schneid Yair |
10% Owner | Buy | 25,000 |
| 2024-02-07 | Schneid Yair |
10% Owner | Buy | 150,000 |
| 2024-02-06 | Schneid Yair |
10% Owner | Buy | 25,000 |
| 2024-02-05 | Schneid Yair |
10% Owner | Buy | 97,402 |
| 2024-01-30 | Schneid Yair |
10% Owner | Buy | 335,000 |
| 2024-01-29 | Schneid Yair |
10% Owner | Buy | 150,000 |
| 2023-07-01 | West Linda |
Director | Award | 23,382 |
| 2023-07-01 | Alleva Lawrence M |
Director | Award | 22,762 |
| 2023-06-14 | LOKAY KEVIN G |
Director | Award | 48,000 |
| 2023-06-14 | Cunningham Emmett |
Director | Award | 48,000 |
| 2023-06-14 | West Linda |
Director | Award | 48,000 |
| 2023-06-14 | Alleva Lawrence M |
Director | Award | 48,000 |
| 2023-06-14 | POWELL MICHAEL |
Director | Award | 64,000 |
| 2023-03-16 | Bachleda Mark |
Chief Commercial Officer | Buy | 11,000 |
| 2023-03-13 | Degnan Chris |
Chief Financial Officer | Buy | 10,000 |
| 2023-03-10 | Sorensen Mel |
Director, President and CEO | Buy | 100,000 |
| 2023-02-25 | Degnan Chris |
Chief Financial Officer | Award | 185,000 |
| 2023-02-25 | Beardsley Robert A |
Chief Operating Officer | Award | 135,000 |
| 2023-02-25 | Sorensen Mel |
Director, President and CEO | Award | 440,000 |
| 2023-02-25 | Bachleda Mark |
Chief Commercial Officer | Award | 135,000 |
| 2023-02-25 | Stacey Jennifer Evans |
See Remarks | Award | 135,000 |
| 2023-02-25 | Kennedy Eugene P. |
Chief Medical Officer | Award | 55,000 |
| 2022-11-21 | Beardsley Robert A |
Chief Operating Officer | Convert | 10,000 |
| 2022-11-21 | Beardsley Robert A |
Chief Operating Officer | Convert | 10,000 |
| 2022-09-12 | Beardsley Robert A |
Chief Operating Officer | Convert | 10,000 |
| 2022-09-12 | Beardsley Robert A |
Chief Operating Officer | Convert | 10,000 |
| 2022-09-01 | Kennedy Eugene P. |
Chief Medical Officer | Award | 150,000 |
| 2022-09-01 | Kennedy Eugene P. |
Chief Medical Officer | Other | 0 |
| 2022-07-18 | Alleva Lawrence M |
Director | Gift | 4,000 |
| 2022-07-01 | West Linda |
Director | Award | 58,496 |
Showing 1–50 of 172 transactions